Gudrun Pohl
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Erythropoietin and Anemia Treatment 3
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 2
- Oncology 19
- Drug Transport and Resistance Mechanisms 9
- Cancer-related Molecular Pathways 5
- Co-authors
- Ie−Ming ShihRobert PirkerMartin FilipitsThomas StranzlTian‐Li WangIe‐Ming ShihRobert J. KurmanMargaretha Rudas
- Journals
- Advances in experimental medicine and biology (2 papers)Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)Cancer Research (2 papers)Blood (2 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Gudrun Pohl
35 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Oncology 579
- Reproductive Medicine 147
- Hematology 183
- Cancer Research 237
- Molecular Biology 661
Countries citing papers authored by Gudrun Pohl
This map shows the geographic impact of Gudrun Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Pohl more than expected).
Fields of papers citing papers by Gudrun Pohl
This network shows the impact of papers produced by Gudrun Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Pohl. The network helps show where Gudrun Pohl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gudrun Pohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 2 | |
| 2 | 2010 | 8 | |
| 3 | 2009 | 8 | |
| 4 | 2008 | 100 | |
| 5 | 2006 | 8 | |
| 6 | 2006 | 16 | |
| 7 | 2006 | 149 | |
| 8 | 2004 | 9 | |
| 9 | 2004 | 143 | |
| 10 | 2003 | 62 | |
| 11 | 2003 | 48 | |
| 12 | 2003 | 29 | |
| 13 | Expression of the lung resistance protein in primary colorectal carcinomas. | 2001 | 3 |
| 14 | Expression of the lung resistance protein (LRP) in primary breast cancer. | 2000 | 18 |
| 15 | 2000 | 47 | |
| 16 | Expression of the multidrug resistance protein (MRP1) in breast cancer. | 2000 | 26 |
| 17 | Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. | 1999 | 39 |
| 18 | 1999 | 26 | |
| 19 | 1999 | 14 | |
| 20 | [Results following reduction mammoplasties. A comparison of selected surgical procedures]. | 1988 | 1 |
About Gudrun Pohl
Gudrun Pohl is a scholar working on Hematology, Oncology, Genetics, Reproductive Medicine and Cancer Research, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Cancer-related Molecular Pathways (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Erythropoietin and Anemia Treatment (3 papers), Acute Myeloid Leukemia Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (579 citations), Reproductive Medicine (147 citations), Hematology (183 citations), Cancer Research (237 citations) and Molecular Biology (661 citations). Gudrun Pohl has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Ie−Ming Shih, Robert Pirker, Martin Filipits, Thomas Stranzl, Tian‐Li Wang, Ie‐Ming Shih, Robert J. Kurman, Margaretha Rudas, R. Jakesz and Heinz Ludwig. Their work appears in journals such as Advances in experimental medicine and biology, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.